packageLithiumSuccinate

lithium succinate

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lithium succinate is a dermatological preparation classified under other dermatologicals, historically used for skin conditions such as seborrhoeic dermatitis. It is currently considered experimental and does not appear to be an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q81988374 and the WHO ATC classification; not checked by a person.

name:lithium succinate
ATC codes:D11AX04
DrugBank:DB14508
Wikidata:Q81988374
formula:C4H4Li2O4
molar mass:129.95 g/mol (knowledgebase (DrugBank calculated))

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown